Enhancing the QUAlity and Transparency Of health Research
Use your browser's Back button to return to your search results
|Reporting guideline provided for?
(i.e. exactly what the authors state in the paper)
|Reporting the results of antimalarial efficacy studies.|
|Full bibliographic reference||Plucinski MM, Ashley EA, Bassat Q, Venkatesan M, Rosenthal PJ, Halsey ES. STARTER Checklist for Antimalarial Therapeutic Efficacy Reporting.
This guideline was published simultaneously in 2 journals. You can read the guideline in either of these journals using the links below.
Am J Trop Med Hyg. 2022;107(1):1-3. PMID: 35880678
Malar J. 2022 Jun 13;21(1):187. PMID: 35698123
|Reporting guideline acronym||STARTER|
|Study design||Clinical trials, Experimental studies|
|Clinical area||Infectious diseases, Tropical medicine|
|Applies to the whole report or to individual sections of the report?||Data, Procedure/Method, Results, Statistical methods and analyses, Study characteristics (participants etc.)|
|Record last updated on||November 3, 2022|
Some reporting guidelines are also available in languages other than English. Find out more in our Translations section.